Fayez Sarofim & Co’s Stryker SYK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $871K | Buy |
2,651
+271
| +11% | +$97.3K | ﹤0.01% | 187 |
|
|
2025
Q4 | $836K | Sell |
2,380
-19
| -0.8% | -$6.92K | ﹤0.01% | 193 |
|
|
2025
Q3 | $887K | Buy |
2,399
+19
| +0.8% | +$7.34K | ﹤0.01% | 198 |
|
|
2025
Q2 | $942K | Hold |
2,380
| – | – | ﹤0.01% | 192 |
|
|
2025
Q1 | $886K | Hold |
2,380
| – | – | ﹤0.01% | 193 |
|
|
2024
Q4 | $857K | Buy |
2,380
+220
| +10% | +$81.5K | ﹤0.01% | 198 |
|
|
2024
Q3 | $780K | Hold |
2,160
| – | – | ﹤0.01% | 190 |
|
|
2024
Q2 | $735K | Hold |
2,160
| – | – | ﹤0.01% | 186 |
|
|
2024
Q1 | $773K | Hold |
2,160
| – | – | ﹤0.01% | 184 |
|
|
2023
Q4 | $739K | Buy |
2,160
+175
| +9% | +$49.1K | ﹤0.01% | 184 |
|
|
2023
Q3 | $542K | Sell |
1,985
-247
| -11% | -$70.8K | ﹤0.01% | 206 |
|
|
2023
Q2 | $681K | Buy |
2,232
+308
| +16% | +$89K | ﹤0.01% | 187 |
|
|
2023
Q1 | $549K | Buy |
1,924
+800
| +71% | +$212K | ﹤0.01% | 208 |
|
|
2022
Q4 | $275K | Hold |
1,124
| – | – | ﹤0.01% | 253 |
|
|
2022
Q3 | $228K | Sell |
1,124
-1,471
| -57% | -$309K | ﹤0.01% | 262 |
|
|
2022
Q2 | $516K | Sell |
2,595
-237
| -8% | -$55.7K | ﹤0.01% | 226 |
|
|
2022
Q1 | $757K | Sell |
2,832
-100
| -3% | -$25.9K | ﹤0.01% | 220 |
|
|
2021
Q4 | $784K | Hold |
2,932
| – | – | ﹤0.01% | 226 |
|
|
2021
Q3 | $773K | Hold |
2,932
| – | – | ﹤0.01% | 214 |
|
|
2021
Q2 | $762K | Hold |
2,932
| – | – | ﹤0.01% | 230 |
|
|
2021
Q1 | $714K | Buy |
2,932
+97
| +3% | +$23.3K | ﹤0.01% | 199 |
|
|
2020
Q4 | $694K | Buy |
2,835
+50
| +2% | +$11.3K | ﹤0.01% | 192 |
|
|
2020
Q3 | $581K | Hold |
2,785
| – | – | ﹤0.01% | 190 |
|
|
2020
Q2 | $501K | Buy |
2,785
+300
| +12% | +$55.3K | ﹤0.01% | 191 |
|
|
2020
Q1 | $414K | Sell |
2,485
-85
| -3% | -$16.6K | ﹤0.01% | 189 |
|
|
2019
Q4 | $540K | Buy |
2,570
+85
| +3% | +$17.6K | ﹤0.01% | 198 |
|
|
2019
Q3 | $538K | Hold |
2,485
| – | – | ﹤0.01% | 189 |
|
|
2019
Q2 | $510K | Buy |
2,485
+200
| +9% | +$38.2K | ﹤0.01% | 192 |
|
|
2019
Q1 | $451K | Sell |
2,285
-100
| -4% | -$18K | ﹤0.01% | 193 |
|
|
2018
Q4 | $374K | Sell |
2,385
-137
| -5% | -$22.9K | ﹤0.01% | 191 |
|
|
2018
Q3 | $448K | Hold |
2,522
| – | – | ﹤0.01% | 192 |
|
|
2018
Q2 | $426K | Hold |
2,522
| – | – | ﹤0.01% | 195 |
|
|
2018
Q1 | $406K | Hold |
2,522
| – | – | ﹤0.01% | 197 |
|
|
2017
Q4 | $391K | Buy |
2,522
+137
| +6% | +$20.9K | ﹤0.01% | 198 |
|
|
2017
Q3 | $338K | Hold |
2,385
| – | – | ﹤0.01% | 208 |
|
|
2017
Q2 | $331K | Hold |
2,385
| – | – | ﹤0.01% | 211 |
|
|
2017
Q1 | $314K | Hold |
2,385
| – | – | ﹤0.01% | 216 |
|
|
2016
Q4 | $286K | Hold |
2,385
| – | – | ﹤0.01% | 220 |
|
|
2016
Q3 | $277K | Hold |
2,385
| – | – | ﹤0.01% | 224 |
|
|
2016
Q2 | $286K | Buy |
+2,385
| New | +$267K | ﹤0.01% | 218 |
|
Other funds holding SYK
VCM
GT
VPM
Fayez Sarofim & Co's SYK Position: Q1 2026 in Review
Fayez Sarofim & Co increased its Stryker (SYK) stake by 11% in Q1 2026, buying an estimated $97.3K and bringing the position to 2,651 shares worth $871K. The position accounts for ﹤0.01% of the portfolio, ranked #187.
Fayez Sarofim & Co first reported a position in SYK in Q2 2016 and has held it in 40 quarters since. The position peaked at $942K in Q2 2025. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.
- Fayez Sarofim & Co held 2,651 shares of Stryker worth $871K as of Q1 2026.
- Fayez Sarofim & Co bought 271 Stryker shares in Q1 2026, an estimated $97.3K.
- Stryker made up ﹤0.01% of Fayez Sarofim & Co's portfolio in Q1 2026, its #187 holding.
- Fayez Sarofim & Co first reported a position in Stryker in Q2 2016 and has held it in 40 quarters since.
- Fayez Sarofim & Co's Stryker position peaked at $942K in Q2 2025.
- 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.
Based on Fayez Sarofim & Co's 13F filing for Q1 2026, filed 15 May 2026.